Grand Pharmaceutical Group Limited (HKG:0512)
8.40
-0.29 (-3.34%)
Aug 1, 2025, 4:08 PM HKT
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 29.42 billion as of August 1, 2025. Its market cap has increased by 79.10% in one year.
Market Cap
29.42B
Enterprise Value
30.18B
Revenue
11.64B
Ranking
n/a
PE Ratio
11.92
Stock Price
8.40
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 29.42B, an increase of 1,965.72%. That is a compound annual growth rate of 10.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 29.42B | 75.00% |
Dec 31, 2024 | 16.81B | 16.78% |
Dec 29, 2023 | 14.39B | -11.29% |
Dec 30, 2022 | 16.22B | -29.24% |
Dec 31, 2021 | 22.93B | -6.10% |
Dec 31, 2020 | 24.42B | 70.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines | 280.47B |
Hansoh Pharmaceutical Group Company | 210.19B |
Innovent Biologics | 167.52B |
JD Health International | 160.97B |
Akeso | 138.77B |
WuXi Biologics | 131.03B |
Sino Biopharmaceutical | 130.92B |
CSPC Pharmaceutical Group | 113.42B |